iBreastExam, is a hand-held, battery powered wireless medical technology that enables affordable and radiation-free breast examination and documentation at the point of care. iBreastExam is clinically validated across multiple independent studies with 7,500 women enrolled. iBreastExam is market cleared by a number of regulators globally including the US FDA, CE Mark and others. Over 500,000 women in 10 countries have received iBreastExam and hundreds of early cancer cases are identified with its help. iBreastExam has received the World Bank’s 2022 Global Women’s Healthtech Award, Innovative Health Technology recognition from the World Health Organization (WHO) and Thought Leader recognition at the 2021 Annual Meeting of the American College of Obstetricians and Gynecologists (by ACOG TV).
The makers of iBreastExam, UE LifeSciences, is a women’s health company focused on preventive oncology. It designs, develops and commercializes medical technology solutions that enable early detection of leading cancers in women.